COVID-19: the Risk to Athletes

Purpose of Review The COVID-19 pandemic has had a profound impact on athletics, and the question of safely resuming competitive sports at all levels has been a source of significant debate. Concerns regarding myocarditis and the risk of arrhythmias and sudden death in athletes have prompted heighten...

Full description

Saved in:
Bibliographic Details
Published in:Current treatment options in cardiovascular medicine 2021-11, Vol.23 (11), p.68-68, Article 68
Main Authors: Goergen, Jack, Bavishi, Aakash, Eimer, Micah, Zielinski, Allison R.
Format: Article
Language:English
Subjects:
Asymptomatic
Athletes
Biomarkers
Cardiac arrhythmia
Cardiology
COVID-19
Edema
Electrocardiography
Heart failure
Hospitalization
Infections
Inflammation
Ischemia
Medical prognosis
Medicine
Medicine & Public Health
Mortality
Myocarditis
Pandemics
Pericarditis
Section Editor
Sports Cardiology (M Wasfy
Sports Cardiology (M Wasfy, Section Editor)
Topical Collection on Sports Cardiology
Viral infections
Young adults
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Purpose of Review The COVID-19 pandemic has had a profound impact on athletics, and the question of safely resuming competitive sports at all levels has been a source of significant debate. Concerns regarding myocarditis and the risk of arrhythmias and sudden death in athletes have prompted heightened attention to the role of cardiovascular screening. In this review, we aim to comprehensively outline the cardiovascular manifestations associated with COVID-19 infection, to discuss screening, diagnosis, and treatment strategies, and to evaluate the current literature on the risk to athletes and recommendations regarding return-to-play. Recent Findings COVID-19 is known to cause myocarditis, with presentations ranging from subclinical current or prior infection detected on cardiac MRI imaging, to fulminant heart failure and shock. While initial data early in the pandemic suggested that the risk of myocarditis could be significant even in patients with nonsevere COVID-19 infection, recent studies suggest a very low prevalence of clinically significant disease in young athletes. Summary While COVID-19 can have significant cardiovascular manifestations, recent data demonstrate that a screening approach guided by severity of COVID-19 infection and cardiovascular symptoms allows the majority of athletes to safely return to play in a timely manner. We must continue to tailor our approach to screening athletes as knowledge grows, and further research on the longitudinal cardiovascular effects of COVID-19 is needed.
ISSN:1092-8464
1534-3189
DOI:10.1007/s11936-021-00941-2